Dr Reddy's Laboratories Limited Friday said its consolidated profit after tax for the quarter-ended March 31, 2019 was up by 44 per cent at Rs 434.4 crore against Rs 302.2 crore in the third quarter of FY 18.
Revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same quarter last fiscal, the city-based drug-maker said in a press release.
The CEO and co-chairman of the company G V Prasad said in the release it has been a good year with a significant turnaround in the financial performance and steady